Pfizer recalls dopamine injection lot; two Phase 3 trials remain not yet recruitingSep 24Weekly roundup, 4 itemsdopaminePfizer
Pfizer posts MET097 obesity results; registers new Phase 3 obesity and dermatitis trialsAug 28Weekly roundup, 6 itemsberobenatidePF-08154225
FDA approves ZAVZPRET label update; Pfizer registers RSVpreF and prostate cancer studiesAug 21Weekly roundup, 7 itemsBioNTech SEPenbraya
Pfizer posts hemophilia results, opens eczema Phase 3, ends two skin studies earlyAug 14Weekly roundup, 6 itemsmarstacimab-hncqPF-06823859
Sign inSign in